 | THE CAMPTOTHECINS: UNFOLDING THEIR ANTICANCER POTENTIAL
Copyright © 2000 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 922:65-75 (2000)
© 2000 New York Academy of Sciences
Mechanisms of DNA Topoisomerase I-Induced Cell Killing in the Yeast: Saccharomyces cerevisiae
PAOLA FIORANI AND
MARY-ANN BJORNSTIa
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38103, USA
aDepartment of Molecular Pharmacology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38103. Voice: 901-495-2315; fax: 901-521-1668.
Mary-Ann.Bjornsti{at}stjude.org
DNA topoisomerase I (Top1) catalyzes the relaxation of supercoiled DNA by a mechanism of transient DNA strand cleavage characterized by the formation of a phosphotyrosyl bond between the DNA end and active site tyrosine. Camptothecin reversibly stabilizes the covalent enzyme-DNA intermediate by inhibiting DNA religation. During S-phase, collisions with advancing replication forks convert these complexes into potentially lethal lesions. To define the DNA damage induced by alterations in Top1p catalysis and the cellular processes that mediate the repair of such lesions, the yeast Saccharomyces cerevisiae was used. Substitution of conserved residues N-terminal to the active site tyrosine (Tyr-727) produced alterations in the camptothecin sensitivity or catalytic cycle of DNA Top1. For example, substituting Ala for Thr-722 in Top1T722A increased the stability of the covalent enzyme DNA intermediate. As with camptothecin, Top1T722A-induced cytotoxicity was ascribed to a reduction in DNA religation. By contrast, enhanced covalent complex formation by Top1N726H resulted from a relative increase in the rate of DNA cleavage. Conditional yeast mutants were also selected that exhibit temperature-sensitive growth only in the presence of the self-poisoning Top1T722A enzyme. Subsequent analyses of these tah mutants identified 9 genes whose function suppresses the cytotoxic action of camptothecin and Top1T722A. These include genes encoding essential DNA replication proteins ( CDC45 and DPB11) and proteins involved in SUMO- or ubiquitination ( UBC9 and DOA4).
This article has been cited by other articles:
|
|
|
|
 
R. C. A. M. van Waardenburg, D. M. Duda, C. S. Lancaster, B. A. Schulman, and M.-A. Bjornsti
Distinct functional domains of ubc9 dictate cell survival and resistance to genotoxic stress.
Mol. Cell. Biol.,
July 1, 2006;
26(13):
4958 - 4969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-A. Bjornsti
TOR Signaling: Another PI3 Kinase Checks in S-Phase
Am. Assoc. Cancer Res. Educ. Book,
April 1, 2006;
2006(1):
77 - 79.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Cheng, S. Shukla, S. Vasunilashorn, S. Mukhopadhyay, and Y.-C. Tse-Dinh
Bacterial Cell Killing Mediated by Topoisomerase I DNA Cleavage Activity
J. Biol. Chem.,
November 18, 2005;
280(46):
38489 - 38495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. R. Jacquiau, R. C. A. M. van Waardenburg, R. J. D. Reid, M. H. Woo, H. Guo, E. S. Johnson, and M.-A. Bjornsti
Defects in SUMO (Small Ubiquitin-related Modifier) Conjugation and Deconjugation Alter Cell Sensitivity to DNA Topoisomerase I-induced DNA Damage
J. Biol. Chem.,
June 24, 2005;
280(25):
23566 - 23575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-A. Bjornsti
Cellular Responses to Replication Stress: Lessons from Yeast
Am. Assoc. Cancer Res. Educ. Book,
April 1, 2005;
2005(1):
250 - 253.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Colley, M. van der Merwe, J. R. Vance, A. B. Burgin Jr., and M.-A. Bjornsti
Substitution of Conserved Residues within the Active Site Alters the Cleavage Religation Equilibrium of DNA Topoisomerase I
J. Biol. Chem.,
December 24, 2004;
279(52):
54069 - 54078.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ferrara and E. B. Kmiec
Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination
Nucleic Acids Res.,
October 5, 2004;
32(17):
5239 - 5248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. V. Walker, K. C. Nitiss, L. H. Jensen, C. Mayne, T. Hu, P. B. Jensen, M. Sehested, T. Hsieh, and J. L. Nitiss
A Mutation in Human Topoisomerase II {alpha} Whose Expression Is Lethal in DNA Repair-deficient Yeast Cells
J. Biol. Chem.,
June 18, 2004;
279(25):
25947 - 25954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Fiorani, R. J. D. Reid, A. Schepis, H. R. Jacquiau, H. Guo, P. Thimmaiah, P. Benedetti, and M.-A. Bjornsti
The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons
J. Biol. Chem.,
May 14, 2004;
279(20):
21271 - 21281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Woo, J. R. Vance, A. R. O. Marcos, C. Bailly, and M.-A. Bjornsti
Active Site Mutations in DNA Topoisomerase I Distinguish the Cytotoxic Activities of Camptothecin and the Indolocarbazole, Rebeccamycin
J. Biol. Chem.,
February 1, 2002;
277(6):
3813 - 3822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Jacobson, C. X. Munoz, K. S. Knox, B. E. Williams, L. L. Lu, F. R. Cross, and E. A. Vallen
Mutations in SID2, a Novel Gene in Saccharomyces cerevisiae, Cause Synthetic Lethality With sic1 Deletion and May Cause a Defect During S Phase
Genetics,
September 1, 2001;
159(1):
17 - 33.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. A. Cliby, K. A. Lewis, K. K. Lilly, and S. H. Kaufmann
S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function
J. Biol. Chem.,
January 4, 2002;
277(2):
1599 - 1606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
